title: The effect of carvacrol on healthy neurons and N2a cancer cells: some biochemical, anticancerogenicity and genotoxicity studies.
abstract: Carvacrol (CVC) is a phenolic monoterpene present in many essential oils of medicinal and aromatic plants and has attracted attention because of its beneficial biological activities. To date, although various biological activities of CVC have been demonstrated, its neurotoxicity on cultured primary rat neurons and N2a neuroblastoma cells has never been explored. Therefore, in this present study, we aimed to describe in vitro antiproliferative and/or cytotoxic properties (by 3-(4,5 dimetylthiazol -2-yl)-2,5 diphenlytetrazolium bromide (MTT) test), genotoxic damage potentials (by single cell gel electrophoresis (SCGE) or Comet assay) and antioxidant activities (by total antioxidant capacity (TAC) and total oxidative stress (TOS) analysis) of CVC in vitro. Dose (0-400 mg/L) dependent effects of CVC were tested on both cultured primary rat neurons and N2a neuroblastoma cells. Statistical analysis of MTT assay results indicated significant (p < 0.05) decreases of cell proliferation rates in both cell types treated with CVC at 200 and 400 mg/L. On the other hand, the mean values of the total scores of cells showing DNA damage (for comet assay) was not found significantly different from the control values for both cells (p > 0.05). In addition, our results indicated that 10, 25 and 50 mg/L of CVC treatment caused increases of TAC levels in cultured primary rat neurons but not in the N2a cell line. However, CVC treatments led to increases of TOS levels in cultured primary rat neurons at only 400 mg/L while they led to increases of TOS levels in N2a neuroblastoma cells at 200 and 400 mg/L. The present findings demonstrated that CVC could be a source of antioxidant and chemopreventive activities to be studied on cancer diseases.
authors.affiliation: Department of Biology, Faculty of Science, Ataturk University, Erzurum, Turkey, elanuraydinn@gmail.com.
authors.forename: Elanur
authors.initials: E
authors.lastname: Aydın
authors.forename: Hasan
authors.initials: H
authors.lastname: Türkez
authors.forename: M Sait
authors.initials: MS
authors.lastname: Keleş
references.citation: Oncology (Williston Park). 1997 Dec;11(12):1857-66; discussion 1869-72, 1875
references.pmid: 9436190
references.citation: J Nutr. 2002 Jun;132(6 Suppl 2):1598S-603S
references.pmid: 12042468
references.citation: Cytotechnology. 2012 Mar;64(2):181-6
references.pmid: 22134772
references.citation: Environ Toxicol. 2008 Dec;23(6):728-35
references.pmid: 18361405
references.citation: J Nutr. 1997 May;127(5):668-74
references.pmid: 9164984
references.citation: Food Chem Toxicol. 2004 Apr;42(4):659-66
references.pmid: 15019191
references.citation: Biotechniques. 1999 Nov;27(5):926-30
references.pmid: 10572638
references.citation: Clin Biochem. 2005 Dec;38(12):1103-11
references.pmid: 16214125
references.citation: Evid Based Complement Alternat Med. 2012;2012:818261
references.pmid: 21760828
references.citation: Adv Exp Med Biol. 1999;464:49-62
references.pmid: 10335385
references.citation: Environ Mol Mutagen. 2000;35(3):206-21
references.pmid: 10737956
references.citation: Pediatr Blood Cancer. 2005 Feb;44(2):147-57
references.pmid: 15390360
references.citation: Ann Neurol. 1994 Nov;36(5):747-51
references.pmid: 7979220
references.citation: Anticancer Res. 2004 Mar-Apr;24(2B):943-54
references.pmid: 15161048
references.citation: Nutr Cancer. 1997;28(1):30-5
references.pmid: 9200147
references.citation: Basic Clin Pharmacol Toxicol. 2010 Dec;107(6):949-57
references.pmid: 20849525
references.citation: Pediatr Blood Cancer. 2007 Jul;49(1):41-6
references.pmid: 16628557
references.citation: BMC Cancer. 2010 Nov 04;10:602
references.pmid: 21050441
references.citation: Cytotechnology. 2003 Nov;43(1-3):149-54
references.pmid: 19003220
references.citation: Molecules. 2012 Apr 26;17(5):4836-50
references.pmid: 22538487
references.citation: J Nat Prod. 1995 Feb;58(2):217-25
references.pmid: 7769390
references.citation: J Nat Med. 2011 Jul;65(3-4):568-77
references.pmid: 21604090
references.citation: Neoplasma. 2007;54(2):108-12
references.pmid: 17319782
references.citation: Clin Biochem. 2004 Feb;37(2):112-9
references.pmid: 14725941
references.citation: Phytomedicine. 2003 May;10(4):292-9
references.pmid: 12809359
references.citation: Life Sci. 2004 Mar 12;74(17):2157-84
references.pmid: 14969719
references.citation: J Nutr. 2000 Apr;130(4S Suppl):1026S-31S
references.pmid: 10736375
references.citation: Arch Pharm Res. 2012 Mar;35(3):565-71
references.pmid: 22477204
references.citation: J Carcinog. 2009;8:9
references.pmid: 19465777
references.citation: Cancer Lett. 1998 Jul 17;129(2):173-9
references.pmid: 9719459
references.citation: Cytotechnology. 2012 Dec;64(6):687-99
references.pmid: 22453904
references.citation: J Nat Prod. 2012 Sep 28;75(9):1511-7
references.pmid: 22967040
references.citation: Oncol Rep. 2008 Sep;20(3):625-30
references.pmid: 18695915
references.citation: Neoplasma. 2011;58(1):14-9
references.pmid: 21067261
references.citation: Drug Chem Toxicol. 2001 Feb;24(1):63-73
references.pmid: 11307635
references.citation: Cytotechnology. 2012 Aug;64(4):459-64
references.pmid: 22262123
references.citation: Fitoterapia. 2011 Jul;82(5):742-9
references.pmid: 21459136
references.citation: Cytotechnology. 2012 Jan;64(1):15-25
references.pmid: 21938470
references.citation: Exp Toxicol Pathol. 2011 Jul;63(5):453-7
references.pmid: 20346638
references.citation: Drug Chem Toxicol. 2006;29(3):313-22
references.pmid: 16777709
references.citation: Biochem Pharmacol. 1997 Jun 1;53(11):1649-57
references.pmid: 9264317
references.citation: J Neurochem. 2006 Jun;97(6):1634-58
references.pmid: 16805774
references.citation: Life Sci. 2004 Jul 9;75(8):955-67
references.pmid: 15193956
references.citation: Phytomedicine. 2010 Jul;17(8-9):581-8
references.pmid: 20096548
references.citation: Cytotechnology. 2012 Jan;64(1):43-51
references.pmid: 21938469
references.citation: Int J Oncol. 2012 May;40(5):1683-90
references.pmid: 22200837
references.citation: PLoS One. 2012;7(3):e33584
references.pmid: 22438954
references.citation: Exp Cell Res. 1988 Mar;175(1):184-91
references.pmid: 3345800
references.citation: Mol Cell Biochem. 2012 Oct;369(1-2):183-93
references.pmid: 22763672
references.citation: Food Chem Toxicol. 2009 Aug;47(8):2037-43
references.pmid: 19477215
references.citation: Cytotechnology. 2010 Apr;62(2):157-65
references.pmid: 20431944
references.citation: Pharmacol Ther. 2001 Oct;92(1):57-70
references.pmid: 11750036
references.citation: J Biol Chem. 2005 Feb 18;280(7):5636-45
references.pmid: 15533929
references.citation: Oncogene. 1996 Oct 17;13(8):1605-14
references.pmid: 8895505
references.citation: Cytotechnology. 2003 Nov;43(1-3):145-8
references.pmid: 19003219
references.citation: Integr Cancer Ther. 2004 Dec;3(4):333-41
references.pmid: 15523104
references.citation: Pediatr Clin North Am. 2008 Feb;55(1):97-120, x
references.pmid: 18242317
references.citation: Food Chem Toxicol. 1999 Aug;37(8):813-23
references.pmid: 10506004
references.citation: Toxicol In Vitro. 2004 Aug;18(4):457-65
references.pmid: 15130603
references.citation: Toxicol Ind Health. 2013 Aug;29(7):584-90
references.pmid: 22317822
references.citation: Appl Environ Microbiol. 1999 Oct;65(10):4606-10
references.pmid: 10508096
references.citation: Carcinogenesis. 1996 Nov;17(11):2367-75
references.pmid: 8968050
references.citation: Neoplasma. 2007;54(6):478-83
references.pmid: 17949230
references.citation: Cell Mol Life Sci. 2008 Oct;65(19):2979-99
references.pmid: 18516495
references.citation: Cytotechnology. 2012 Dec;64(6):679-86
references.pmid: 22447390
references.citation: Neurochem Int. 1998 Feb;32(2):117-31
references.pmid: 9542724
references.citation: Anticancer Res. 2006 May-Jun;26(3A):1903-8
references.pmid: 16827123
references.citation: Biochem Pharmacol. 2005 May 15;69(10):1421-32
references.pmid: 15857606
references.citation: Cytotechnology. 2012 Dec;64(6):607-12
references.pmid: 22526492